Ledger.Open graph →
SEC Form D · filed April 29, 2021

Boston Biopharma, Inc

Offering
—
Sold
$1.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
ROSWELL, GA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Peter G. Wodtke · Washington, CTDirectorAhmad Hashem · Roswell, GAExec · DirectorAmmar K. Hemaidan · Port Orange, FLDirectorTerry K. Clark · Palmer, AKDirectorPeter G. Wodtke · Washington, CTDirectorAhmad Hashem · Roswell, GAExec · DirectorAmmar K. Hemaidan · Port Orange, FLDirectorTerry K. Clark · Palmer, AKDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗